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Background: Dengue fever is perhaps the most important viral re-emergent disease especially in tropical and sub-
tropical countries, affecting about 50 million people around the world yearly. In Colombia, dengue virus was first
detected in 1971 and still remains as a major public health issue. Although four viral serotypes have been
recurrently identified, dengue virus type 2 (DENV-2) has been involved in the most important outbreaks during the
last 20 years, including 2010 when the fatality rate highly increased. As there are no major studies reviewing virus
origin and genotype distribution in this country, the present study attempts to reconstruct the phylogenetic
history of DENV-2 using a sequence analysis from a 224 bp PCR-amplified product corresponding to the carboxyl
terminus of the envelope (E) gene from 48 Colombian isolates.
Results: As expected, the oldest isolates belonged to the American genotype (subtype V), but the strains collected
since 1990 represent the American/Asian genotype (subtype IIIb) as previously reported in different American
countries. Interestingly, the introduction of this genotype coincides with the first report of dengue hemorrhagic
fever in Colombia at the end of 1989 and the increase of cases during the next years.
Conclusion: After replacement of the American genotype, several lineages of American/Asian subtype have rapidly
spread all over the country evolving in new clades. Nevertheless, the direct association of these new variants in the
raise of lethality rate observed during the last outbreak has to be demonstrated.
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Background
During the last few decades, the whole world has faced
the re-emerging of different infectious diseases, being
dengue one of the most important in terms of morbidity
and mortality [1-5]. Dengue virus (DENV) is an arbo-
virus belonging to family flaviviridae and is responsible
of a wide range of clinical manifestations in humans,
including an acute self-limited flu-like illness known as
dengue fever (DF) or a severe illness known as dengue
hemorrhagic fever (DHF) characterized by a marked
plasma leakage, which may progress to hypovolemic
shock (dengue shock syndrome, DSS) with circulatory
failure [1,3,4,6-8]. Nevertheless, changes observed in
clinical manifestations (in terms of severity) during the
few last years have obliged to redefine this classification
according to the presence of alarm signs [4].
As usual in flavivirus, DENV is an enveloped virus
with a positive sense ssRNA of about 11 kb coding a
single open reading frame for three structural proteins,
core (C), membrane (M) and envelope (E), and seven
non-structural proteins (NS1, NS2A, NS2B, NS3, NS4A,
NS4B, NS5). Based on serological analysis, DENV can
be differentiated as four distinct serotypes (DENV-1,
DENV-2, DENV-3 and DENV-4), which are capable of
causing the disease. Although the exact mechanisms for
DHF remains unclear, it is generally accepted that a sec-
ondary infection with a heterologous serotype increases
the risk of severe manifestations as a consequence of
the antibody dependent enhancement (ADE) mechanism
proposed by Halsted in the 80’s[ 7 ] .H o w e v e r ,a na l t e r -
native explanation to patho-physiology of DHF is the
emergence and spread of virulent strains originated as
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any medium, provided the original work is properly cited.part of an evolutionary process [2,9,10]. In fact, molecu-
lar epidemiology using nucleotide sequence analysis
from the DENV genome has demonstrated the occur-
rence of genotype clades within each serotype [11-29],
which highlights the important role of DENV itself in
disease severity rather than immune enhancement
[2,9,10].
The four serotypes of DENV have been circulating in
the Americas since the early 1900’s, generating only
slight cases of DF and sporadic cases of severe disease
[1,5,6,30]. It was not until 1981 when the first large epi-
demic of DHF occurred in Cuba and rapidly spread to
Jamaica (1981-1982), Brazil (1986), and Venezuela
(1989-1990) [1,2,5,8,9,12,23]. In Colombia, the first case
of DHF was officially notified in December of 1989 from
the village of Puerto Berrio (Antioquia department)
[25,31]. Since then, DHF became endemic and lethal
cases rapidly increased during the next years. Although
co-circulation of serotypes was common in different
countries, samples from these major outbreaks con-
firmed DENV-2 as the main responsible of DHF cases.
I n1 9 9 7 ,R i c o - H e s s ee ta l . ,d e m o n s t r a t e dt h a tD E N V - 2
isolated from DHF outbreaks in Jamaica and the Carib-
bean islands (and possibly Cuba) in 1981-1982 belonged
t oan e wc l a d ef o r m e r l yn a m e d“Asian genotype”, prob-
ably introduced from South Asia, where severe infection
has been persistent since the middle of the past century
[2,23]. To date, DENV-2 falls into seven subtypes (or
genotypes) designed as Subtype I (Asian II), Subtype II,
Subtype IIIa (Asian I), Subtype IIIb (American/Asian),
Subtype IV (Cosmopolitan), Subtype V (American) and
Sylvatic genotype [2,12,13]. Additionally, the existence
of clades with distinctive geographical and temporal
relationships has been suggested [23].
Historically, Colombia has been one of the most
affected countries in the Americas with dengue epi-
demics [6,30,31]. In fact, during the last year it went
through the largest dengue epidemic occurred in dec-
ades, with 157,152 cases notified (mostly DENV-2) and
217 deaths confirmed [32]. Nevertheless, there are no
major studies regarding DENV-2 phylogenetic origin or
genotype circulation and distribution [25]. Conse-
quently, the present study tries to reconstruct phyloge-
netics of DENV-2 virus that has been circulating in
Colombia during the 1980’s in comparisons to the
strains isolated since the emergence of DHF. In addi-
tion, this work describes the evolution of new clades
during the last decade based on a partial nucleotide
sequence of the envelope (E) gene.
Results
Virus recovery and confirmation
Forty-eight viruses obtained from symptomatic patients
were isolated in mosquito cell culture and subsequently
identified as DENV-2 serotype by monoclonal antibodies
and confirmed by RT-PCR methods [33]. Isolates are
listed in Table 1 indicating locality, isolation year, geno-
type and accession number.
Phylogenetic reconstruction of DENV-2
Sequences from the carboxyl terminus of the envelope
(E) gene from the 48 Colombian DENV-2 isolates were
aligned in CLUSTAL W [34,35] and compared with 28
previously reported sequences elsewhere, resulting in a
trivial alignment as long as there were not insertions or
deletions (INDELS). Although the use of the whole E
protein gene is highly recommended to reconstruct
DENV phylogenies, the 224 bp sequence used in our
study has been demonstrated to be useful to infer phylo-
genetic relationships while the topology is fully main-
tained [26,27,29].
The Maximum Likelihood (ML) approach using only
Colombian isolates and one sylvatic strain to root the
tree (Figure 1), clearly shows two major clades, one
involved mainly viruses isolated between years 1982 to
1988 and the other one mostly viruses isolated since
1990.
In order to associate those clades, the ML tree was
reconstructed using all previously defined DENV-2 sub-
types [Subtype I (Asian II), Subtype II, Subtype IIIa
(Asian I), Subtype IIIb (American/Asian), Subtype IV
(Cosmopolitan), Subtype V (American) and Sylvatic gen-
otype] (Figure 2). According to the Akaike Information
Criterion (AIC), the model that better fitted the data
was the Tamura-Nei equal transversion frequencies
(TrNef) model. Fourteen Colombian isolates (13
reported for the first time and 1 previously described)
grouped into the Subtype V clade (American genotype)
close to the oldest strains from Tahiti (DENV-2/PF/
Tahiti/1971; DENV-2/PF/Tahiti/1973), Trinidad
(DENV-2/TT/257/1972; DENV-2/TT/565/1972; DENV-
2/TT/572_CDC/1983) and the latest detected in Central
(DENV-2/HN/1991; DENV-2/CR/CRA_94/1994; DENV-
2/CR/CRB_94/1994) and North America (DENV-2/MX/
1995). Thirteen out of these Colombian viruses were
isolated between 1982 and 1988. Interestingly, although
the most recent detection of American genotype was in
Peru in 1996, we found one virus isolated in 2002
(DENV-2/CO/355_Guaviare/2002) belonging to this
subtype. To discard cross contamination, RNA of the
sample was newly obtained and re-amplified.
On the other hand, 35 Colombian sequences (34 novel
and 1 previously reported) isolated between 1992 and
2010 belong to Subtype IIIb (American/Asian genotype)
near to DENV-2/JM/Jamaica/1983, the putative first
virus of this genotype introduced into the Americas.
Subtype IIIb is divided in two clades, one representing
the Asian viruses and the other one comprising the
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ISOLATE LOCALITY ISOLATION YEAR SUBTYPE/GENOTYPE ACCESSION NUMBER
DENV-2/CO/186_Tolima/1982 Tolima 1982 V/American JF906211
DENV-2/CO/299_Tolima/1983 Tolima 1983 V/American JF906212
DENV-2/CO/298_Nariño/1983 Nariño 1983 V/American JF906213
DENV-2/CO/183_Nariño/1985 Nariño 1985 V/American JF906214
DENV-2/CO/184_Nariño/1985 Nariño 1985 V/American JF906215
DENV-2/CO/348563_Nariño/1985 Nariño 1985 V/American JF906216
DENV-2/CO/348561_Huila/1985 Huila 1985 V/American JF906217
DENV-2/CO/350447_Tolima/1987 Tolima 1987 V/American JF906218
DENV-2/CO/350446_Tolima/1987 Tolima 1987 V/American JF906219
DENV-2/CO/351863_Cundinamarca/1988 Cundinamarca 1988 V/American JF906220
DENV-2/CO/362091_Caqueta/1988 Caqueta 1988 V/American JF906221
DENV-2/CO/350449_Tolima/1988 Tolima 1988 V/American JF906222
DENV-2/CO/351861_Bolivar/1988 Bolivar 1988 IIIb/American- Asian JF906223
DENV-2/CO/360281_Tolima/1992 Tolima 1992 IIIb/American-Asian JF906224
DENV-2/CO/274_Santander/1997 Santander 1997 IIIb/American-Asian JF906225
DENV-2/CO/271_Santander_1997 Santander 1997 IIIb/American-Asian JF906226
DENV-2/CO/193_Tolima/1997 Tolima 1997 IIIb/American-Asian JF906227
DENV-2/CO/201_Arauca/1998 Arauca 1998 IIIb/American-Asian JF906228
DENV-2/CO/202_Tolima/1998 Tolima 1998 IIIb/American-Asian JF906229
DENV-2/CO/272_Cundinamarca/1998 Cundinamarca 1998 IIIb/American-Asian JF906230
DENV-2/CO/377717_Cundinamarca/1999 Cundinamarca 1999 IIIb/American-Asian JF906231
DENV-2/CO/218/2001 NA 2001 IIIb/American-Asian JF906232
DENV-2/CO/219/2001 NA 2001 IIIb/American-Asian JF906233
DENV-2/CO/355_Guaviare/2002 Guaviare 2002 V/American JF906234
DENV-2/CO/222/2002 NA 2002 IIIb/American-Asian JF906235
DENV-2/CO/357_Tolima/2002 Tolima 2002 IIIb/American-Asian JF906236
DENV-2/CO/376_SanAndres/2003 San Andres 2003 IIIb/American-Asian JF906237
DENV-2/CO/371_Cauca/2003 Cauca 2003 IIIb/American-Asian JF906238
DENV-2/CO/392_Guajira/2003 Guajira 2003 IIIb/American-Asian JF906239
DENV-2/CO/383_Guajira/2003 Guajira 2003 IIIb/American-Asian JF906240
DENV-2/CO/384_Tolima/2003 Tolima 2003 IIIb/American-Asian JF906241
DENV-2/CO/378_Tolima/2003 Tolima 2003 IIIb/American-Asian JF906242
DENV-2/CO/397/2004 NA 2004 IIIb/American-Asian JF906243
DENV-2/CO/402_Putumayo/2004 Putumayo 2004 IIIb/American-Asian JF906244
DENV-2/CO/399_Guajira/2004 Guajira 2004 IIIb/American-Asian JF906245
DENV-2/CO/241_Guaviare/2005 Guaviare 2005 IIIb/American-Asian JF906246
DENV-2/CO/413037_Amazonas/2010 Amazonas 2010 IIIb/American-Asian JF906247
DENV-2/CO/412968_Santander/2010 Santander 2010 IIIb/American-Asian JF906248
DENV-2/CO/413036_Amazonas/2010 Amazonas 2010 IIIb/American-Asian JF906249
DENV-2/CO/412597_Amazonas/2010 Amazonas 2010 IIIb/American-Asian JF906250
DENV-2/CO/413034_Amazonas/2010 Amazonas 2010 IIIb/American-Asian JF906251
DENV-2/CO/413033_Amazonas/2010 Amazonas 2010 IIIb/American-Asian JF906252
DENV-2/CO/408339_Valle/2010 Valle 2010 IIIb/American-Asian JF906253
DENV-2/CO/410149_Cesar/2010 Cesar 2010 IIIb/American-Asian JF906254
DENV-2/CO/408243_Risaralda/2010 Risaralda 2010 IIIb/American-Asian JF906255
DENV-2/CO/408338_Valle/2010 Valle 2010 IIIb/American-Asian JF906256
DENV-2/CO/V-163/1961 NA 1961 I/Asian II JF906257
DENV-2/CO/256/1971 NA 1971 I/Asian II JF906258
NA = Not Available
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(DENV-2/CO/351861_Bolivar/1988) grouped into the
Asian clade, separated from the remaining isolates. In
order to confirm this result, RNA was extracted and
amplified again. Once reconstructed, the tree showed
the same topology. Nevertheless, the bootstrap support
for this node is under 50%.
Two isolates from 1961 and 1971 (DENV-2/CO/V-
163/1961; DENV-2/CO/256/1971) match to the 1944
New Guinea strain (Subtype I/Asian II genotype). How-
ever, it was not possible to establish the origin of those
viruses.
T h ef r a g m e n ta n a l y z e di no u rs t u d yc o r r e s p o n d e dt o
the carboxyl terminus of envelope (E) gene, covering
amino acid 422 to 495 of the E protein. As previously
reported, all the American isolates have Valine (V) at
the position 485, whereas Asian strains have Isoleucine
at the same position [23]. On the other hand, all the
sequences belonging to the Genotype IIIb have Valine at
the position 484 and Alanine at the 491 (only one
Colombian isolate has Valine at this position), while
Genotype V isolates (all of them) have Isoleucine and
Valine respectively.
Using Bayesian inference and according to the 95%
highest posterior density (HPD) under the strict molecu-
lar clock model, the root of the tree including sylvatic
strain is placed around 270 years ago and the substitu-
tion rate was 6.6 × 10
4 substitutions per site per year,
close to the previously reported [20,36-38]. Topology of
the tree (Figure 3) shows two well supported clades
representing American genotype (PP = 0.99) and the
Asian/American genotype (PP = 0.99). Again, all but
one (DENV-2/CO/355_Guaviare/2002) of the Colom-
bian strains isolated between 1982 and 1988 fell into the
subtype V, while those further isolated until 2010 get
into the subtype IIIb. The phylogeny demonstrates a
huge sustained spread of viruses all over the country,
especially during the last 10 years. In fact since the year
2000, Colombian strains have been evolving in different
clades, mostly clustered by thet i m eo fi s o l a t i o n .I n t e r -
estingly, during the last epidemic in 2010, at least two
different lineages had been circulating one in different
localities and one almost exclusively at the Amazonas
department.
Discussion
B e t w e e n1 9 5 0a n d1 9 6 0 ,t h eP a nA m e r i c a nH e a l t h
Organization (PAHO) Aedes aegypti eradication pro-
gram to fight urban yellow fever was successful to sup-
press dengue transmission [5]. By the year 1952 Aedes
aegypti was virtually eradicated from Colombia, and
only few cases of Dengue were reported on the Magda-
lena valley [5,30,31]. Unfortunately, predictions made by
Dr. Hernando Groot about the real impact of dengue in
the Americas were ignored and the implementation of
these eradication campaigns were abandoned by the late
60’s and the subsequent decades, leading the mosquitoes
to proliferate and spread all over the American conti-
nent [30]. Dengue syndrome re-emerged and rapidly
became the most important infectious viral disease in
the Americas [1,4,5,30,31]. Since then, all DENV sero-
types have been detected, being DENV-2 perhaps the
most important in terms of morbidity and mortality
[1,4,5,30,31].
We have reconstructed the phylogenetic history of
DENV-2 in Colombia and reported for the first time the
distribution of genotypes across time. Large epidemics
of DENV-2 were first occurred in the Caribbean Islands,
starting in Trinidad & Tobago (1953), following by Cur-
ação and Haití (1968) [1,5]. First outbreaks of DENV-2
reported in mainland, probably as a spillover from the
islands, occurred in French Guiana (1970) and Colombia
(1971) [1,5,30,31]. For about 10 years, the virus was
reported only in Colombia where it was generating DF
until 1981, when this serotype was first reported in
Cuba and Jamaica [1,5,8]. Our study clearly demon-
strates that Colombian DENV-2 isolated up to 1988
Figure 1 Evolutionary relationships of Colombian DENV-2.
Phylogenetic tree of 52 DENV-2 Colombian isolates was computed
using the Maximum Likelihood method. Nodes with significant
Neighbor- Joining bootstrap values (≥ 50) are indicated. The tree is
drawn to scale, with branch lengths in the same units as those of
the evolutionary distances used to infer the phylogenetic tree. Two
well defined clades are shown in red and blue. The tree is rooted
using one Sylvatic sequence.
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Page 4 of 11Figure 2 Evolutionary relationships of DENV-2. Phylogenetic tree of 52 DENV-2 Colombian isolates and 24 worldwide previously reported
was computed using the Maximum Likelihood method. Nodes with significant Neighbor-Joining bootstrap values (≥ 5)are indicated. The tree is
drawn to scale, with branch lengths in the same units as those of the evolutionary distances used to infer the phylogenetic tree. American
genotype (Subtype V) and Colombian isolates belonging to this clade are show in red. American/Asian genotype (Subtype IIIb) and Colombian
isolates belonging to this clade are show in blue. The tree is rooted using one sylvatic sequence.
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previously defined as Subtype V (American genotype)
[2,12,13]. One of the most significant issues of dengue
history in the Americas is perhaps the first DHF out-
break occurred simultaneously in Cuba and Jamaica in
1981 [1,8,23,39,40]. Further studies demonstrated that
DENV-2 involved in this severe epidemic belonged to a
different genotype very close to previously characterized
Asian strains [2,12,23,39,40]. This new Asian-American
virus (currently known as Subtype IIIb) generates a well
supported clade, nested Jamaica strains above (DENV-2/
JM/Jamaica/1983) and Vietnam and China as the origin
of subclade (DENV-2/CN/1985; DENV-2/VN/CTD44/
1988; DENV-2/VN/CTD28/1997). Thirty-five (35) out of
the 36 Colombian viruses isolated after year 1990 fell
into this clade, demonstrating the spread of the Asian-
American genotype all over the country during the last
20 years. Interestingly, the introduction of this subtype
clearly coincides with the first official report of DHF at
the end of 1989 (Puerto Berrio, Antioquia) and the sus-
tained increase of severe cases observed during the next
years [30]. Two major explanations have been suggested
Figure 3 Molecular Clock of DENV-2.D E N V - 2d i v e r g e n c et i m ew a se s t i m a t e du s i n gy e a ro fisolation (scale used in the tree) as calibration
points under the strict molecular clock model using GTR + Γ + I parameters. Posterior Probability (PP) values are indicated for each node, and
the blue bars represent the extent of the 95% highest posterior density (HPD) intervals for each divergence time. American genotype (Subtype
V) and Colombian isolates belonging to this clade are show in red. American/Asian genotype (Subtype IIIb) and Colombian isolates belonging to
this clade are show in blue.
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ment (ADE) theory proposes the rise of severity as a
result of a secondary heterologous infection, essentially
in hyperendemic areas [7]. However, in Colombia the 4
serotypes were circulating already (DENV-3 in 1975,
DENV-1 since 1978, DENV-4 since 1983) and yet, there
were not DHF cases reported even in those localities
were co-circulation of at least 2 serotypes was noted.
On the other hand, the sudden increase in DHF cases
after the introduction of the Subtype IIIb in the Ameri-
cas (probably in Jamaica in 1981) supports the idea of
the emerging of virulent strains (hemorrhagic strains)
and replace of the less aggressive native American geno-
types [2,9,10,12]. The marked split showed in our study
between the isolates obtained before and after the
appearance of DHF, clearly agrees with the second
hypothesis, although the first one can explain the high
incidence of severe dengue currently observed in some
hyperendemic localities with co-circulation of serotypes
others than DENV-2. In fact, during the last epidemic in
Colombia (2010) DENV-1 and DENV-2 were isolated in
high proportion equally in both DF and DHF cases but
secondary infection was not demonstrated. Moreover, all
four serotypes were detected in fatal cases, even though
DENV-2 was the most frequent [32]. All together, these
findings suggest that hyperendemicity summed to
increased virulence are both decisive for DHF mainte-
nance, more than two separate factors [2,9,10,12].
The introduction of the DENV-2 American genotype
in Colombia is easy to explain, considering that the A.
aegypti eradication programs failed in the Caribbean
coast, leading the mosquito spread from Maracaibo
(Venezuela) to Maicao (La Guajira, Colombia) in 1968
[30,31]. By the year 1971, the entire Colombian Atlantic
coast was re-infested, including most of the important
ports located in Barranquilla (Atlántico) and Cartagena
(Bolivar), which maintained major commercial trades
with the Caribbean islands where the virus was already
established.
More difficult to explain is the replacement event of
the American genotype by the Asian- American [2,12].
Since the introduction of Subtype IIIb, American had
been detected only in few cases during the middle 90’s
in Central America and as late as 1996 in Peru [41].
The replacement and extinction of genotypes have been
described as a stochastic event occurring during periods
of depletion in mosquitoes population or low number of
susceptible hosts [20,38,42-46]. In the present study we
found one virus isolated in 2002 (DENV-2/CO/
355_Guaviare/2002) placed inside the Subtype V (Amer-
ican genotype), indicating perhaps that the genotype is
not extinct. Although differences in fitness have not
been surely demonstrated (see below), it is possible for
the Asian genotypes to hold a higher transmission
pattern, restricting the “native” virus to low circulation
dynamics and probably causing only subclinical (unde-
tectable) infections. On this matter, it is important to
notice that the samples collected come from the surveil-
lance system and belong to symptomatic patients.
Therefore, the opportunity to isolate this genotype again
is even lower.
There are two major pressures affecting DENV evolu-
tion process. One is the attachment to a susceptible cell,
leading to entry by membrane fusion and the other is
the host immune response [18,20,38,47-51]. The envel-
ope (E) protein is involved in both processes and there-
fore the most representative to infer adaptation patterns.
In fact, Weaver et. al. had demonstrated the constrained
effect occurring in virus obligated to alternate between
invertebrate vector and vertebrate host [52,53]. Never-
theless, this effect is possible reduced when transmission
rates are very high (hyperendemic areas) in human
hosts [29]. On the other hand, positive selection on
some DENV-2 genotypes had been previously inferred
into immunogenic zones of E protein, specifically in
amino acids 91, 129, 131 and 491, indicating perhaps a
way for immune response evasion [18,20,23,49]. Accord-
ing to our results and as previously reported, all the
American isolates have Valine at the position 485,
whereas Asian strains have Isoleucine at the same posi-
tion [23]. Interestingly, Valine at 484 and Alanine at 491
were conserved all over the Genotype IIIb, while Geno-
type V isolates have Isoleucine and Valine at the same
positions clearly resembling the ancestral state observed
in sylvatic strains (Malaysia, DENV-2/MY/Sylvatic/1970)
[54]. Although the impact of this phenotypic change (if
any) remains to be determined, but it strongly suggests
a positive selection process acting over the E protein
[49,50].
Evolution dynamics of DENV-2 is affected by several
factors. Because of the lack of proof-reading activity of
RNA-dependent RNA-polymerase, RNA viruses usually
present higher mutation rates than DNA viruses
[47,55-57]. Nevertheless, arboviruses (as mentioned
above) are subject to a trade-off effect when they alter-
natively replicate in humans and mosquitoes [52,53]. In
fact, Holmes had demonstrated that arboviruses (in gen-
eral) generate more deleterious mutation than other
RNA viruses. [51]. As a consequence, susceptible human
populations together with vector densities might lead
different evolution patterns in distinct geographic areas.
Colombia is perhaps one of the most highly endemic
countries in the Americas region, with a current co-cir-
culation of the four DENV serotypes and 75% of the ter-
ritory having elevated rates of A. aegypti infestation
[31,32]. Moreover, by the year 2010, 157,152 cases of
dengue were confirmed including 9.482 corresponding
to DHF with 2.28% of lethality [32]. During this time,
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DENV-2. In spite of the constrained effect, our results
of the Bayesian analysis clearly show an intense evolu-
tion process, supported by the different clades generated
since the first circulation. According to the tree, Subtype
IIIb Colombian isolates fall into at least 3 clades or
“lineages” especially well defined after the year 2000.
One clade put together most of the samples collected
between 2001 and 2004. The second clade groups
mainly viruses isolated in 2005 (DENV-2/CO/241_Gua-




there is a third clade clustering almost exclusively with
strains from Amazonas department (only one from San-
tander) isolated during the last epidemic (2010). Until
2009, there was not dengue transmission in the Amazo-
nas because of the small A. aegipty population, and only
sporadic cases of imported infection had been notified
[30]. Nevertheless, in 2010 the number of dengue
patients significantly increased in Leticia, the capital city
of Amazonas [32]. Epidemiological surveillance system
let us confirm that most of that reported cases came
from the neighbor Peruvian city of Iquitos, where a den-
gue outbreak was already taking place. Together, these
results demonstrate the establishment and co-circulation
of different lineages of the Asian/American genotype
during the last decade, and the entrance of a new one
during the last Colombian epidemic.
In conclusion, our phylogenetic reconstruction sug-
gests the circulation of DENV-2 American Subtype V in
Colombia for about 20 years, until the early 90’sw h e n
the Asian/American Subtype IIIb replaced it. Although
the first entry and subsequent establishment of this new
genotype clearly coincide with the emerging and
increase of severe DHF, there is no formal evidence of
enhanced virulence on this genotype. On the other
hand, during the last 20 years Subtype IIIb has been
evolving locally and co-circulation of different clades is
observed. In fact, introduction of a new “lineage” prob-
ably from Peru to the Colombian Amazon region is
strongly supported. Even with the lack of viral patho-
genic markers certainly documented, it is compelling
that the clinical manifestation of dengue infection has
changed. Atypical signs such as viscerotropism or ence-
phalitis are becoming more recurrent and lethality rates
are increasing in hyperendemic countries including
Colombia. Therefore, control programs should include
the surveillance of potentially pathogenic DENV geno-
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the virus collection of the National Health Institute
(INS, Virology Lab, Bogotá, Colombia), and comprised
48 isolates from different outbreaks, epidemics and rou-
tine epidemiological surveillance. Clinical samples were
collected between 1982 and 2010 from different local-
ities all around the country, so they represent most
viruses circulating in Colombia during the last 30 years
(Table 1). All viral stocks were inoculated on C6/36
Aedes albopictus cells growing in Eagle’s minimal essen-
tial medium (E-MEM) supplemented with 2% fetal calf
serum (FSC). After 10 days of incubation at 28°C,
monolayer was disrupted and supernatant was then
recovered by centrifugation and stored at -80°C until
use. The remained cells were washed with Phosphate
Buffer Saline (PBS) and dripped on slides; after fixed in
cool acetone, slides were incubated with monoclonal
antibodies (anti-DENV-1 to anti-DENV-4, kindly
donated by CDC, Puerto Rico) for one hour, washed
with PBS and incubated again with a fluorescent conju-
gated antibody. Additionally, DENV-2 serotype confir-
mation was done by reverse transcription polymerase
chain reaction (RT-PCR) using specific primers [33].
Viral RNA extraction, RT-PCR and sequencing
Cell culture supernatants were used to extract viral RNA
using QIAamp Viral RNA Minikit (Qiagen, Germany)
following manufacturer’s instructions. Briefly, 140 μlo f
each supernatant was placed into 560 μlo fA V Lb u f f e r
with 5.6 μl of carrier RNA and mixed with ethanol (96-
100%) before passed through a column by centrifuga-
tion. After washing with buffers AW1 and AW2 RNA
was finally eluted with 60 μl of AVE buffer and stored
at -80°C until use. Five micro liters from each RNA
extraction were used as template in a one step RT-PCR
reaction (Qiagen, One-Step RT-PCR kit) as previously
described [33]. Primers used [DEN2S1871 (5’-TAGCA-
GAAACACARCATGGNAC-3’) and DEN2AS2622 (5’-
CAATTCTGGTGTTATTTGYTTCCAC-3’)] were desig-
nated to amplify 751 bp from the joining region E/NS1.
Reactions were evaluated in 1% agarose gels stained
with ethidum bromide and negative reactions were sub-
jected to nested PCR as previously reported [29,33],
using specific nested primers DEN2S2042 (5’-CAGT-
CAACATAGAAGCAGAACC-3’) and DEN2AS2549 (5’-
GCYGAAGCTAGTTTTGAAGGGG-3’)]. Nested PCR
was evaluated in 1% agarose gel stained with ethidium
bromide.
Amplified products (from RT-PCR or nested PCR)
were purified using QIAquick PCR Purification Kit
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Page 8 of 11(QIAGEN, Germany) and then used as template for
sequencing reactions using the ABI Prism Dye Termina-
tor Cycle Sequencing Ready Reaction Kit (Applied Bio-
systems, Foster City, CA) [29,33]. A total of 224 bp
[corresponding to carboxyl terminus of envelope (E)
gene] from 48 new sequences were compared with 28
previously sequenced strains from all over the world,
available in GenBank. Consensus sequences were aligned
using the program CLUSTAL W included in MEGA
package version 4.0 [34,35].
Phylogenetic analyses
Phylogenetic trees were reconstructed with the Maxi-
mum Likelihood (ML) methods incorporated in the Par-
alleled and Integrated Framework for Phylogenetic
Inference with Automatic Likelihood Model Selector
(PALM) program, which combines Clustal W, PhyML,
MODELTEST, ProtTest and others in one interface.
[34,35,58-60]. Statistical significance of tree topology
was assessed with a bootstraping with 1000 replicates.
Obtained trees were visualized using the FigTree 1.2.2.
program. All the ML and MODELTEST parameters
obtained are available upon request.
Substitution rates and molecular clock
In addition, estimated rate of evolutionary change
(nucleotide substitutions per site per year) and tree root
age was obtained with the program BEAST (Bayesian
Evolutionary Analysis by Sampling Trees) [61], which
uses Bayesian Markov Chain Montecarlo (MCMC) algo-
rithms combined with the chosen model and prior
knowledge of sequence data to infer the posterior prob-
ability distribution of phylogenies [61-65]. We analyze
the data using the year of isolation as calibration points
to estimate divergence time in years. Rate variation
among branches was inferred under the strict molecular
clock model, whereas substitution rate among sites was
calculated with the General Time-Reversible model
(GTR) combined with the gamma parameter and pro-
portion of invariant sites (GTR + Γ +I )m o d e l .M C M C
was run for 10,000,000 steps and sampled every 500
steps and the 10,000 first steps of each run were dis-
carded. BEAST format files were obtained in the pro-
vided BEAUti graphical interface and the trees were
visualized with the FigTree 1.2.2. program. Finally, sta-
tistical analyze were carried out in the Tracer package
[61].
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